Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer

समान संसाधन

• Oncogenic and drug sensitive NTRK1 rearrangements in lung cancer
  द्वारा: Vaishnavi, A., और अन्य
  प्रकाशित: (2013)
• Resistance to ROS1 Inhibition Mediated by EGFR Pathway Activation in Non-Small Cell Lung Cancer
  द्वारा: Davies, Kurtis D., और अन्य
  प्रकाशित: (2013)
• Resistance to ROS1 Inhibition Mediated by EGFR Pathway Activation in Non-Small Cell Lung Cancer
  द्वारा: Kurtis D. Davies, और अन्य
  प्रकाशित: (2013)
• An Oncogenic <i>NTRK</i> Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101
  द्वारा: Robert C. Doebele, और अन्य
  प्रकाशित: (2015)
• Identification of existing drugs that effectively target NTRK1- and ROS1-rearrangements in lung cancer
  द्वारा: Chong, Curtis R., और अन्य
  प्रकाशित: (2016)